CAS: 467443-01-2; 2-(3-Nitrophenyl)-1,3,2-Dioxaborolane-4R,5R-Dicarboxylic Acid

英文名称2-(3-Nitrophenyl)-1,3,2-Dioxaborolane-4R,5R-Dicarboxylic Acid
中文名称3-硝基苯硼酸l-酒石酸酯
IUPAC名称(4R,5R)-2-(3-nitrophenyl)-1,3,2-dioxaborolane-4,5-dicarboxylic acid
其它别名(4R,5R)-2-(3-Nitrophenyl)-1,3,2-Dioxaborolane-4,5-Dicarboxylic Acid; 2-(3-Nitrophenyl)-1,3,2-Dioxaborolane-4R,5R-Dicarboxylic Acid; 3-Nitrophenylboronic Acid L-Tartaric Acid Ester; L-Tarb-No2; 1,3,2-Dioxaborolane-4,5-
CAS编号467443-01-2
MFCD编号:MFCD09750458
分子式:C10H8BNO8分子量:280.98
产品CID: 1463932
产品分类有机原料→分子砌块→芳环类化合物→苯类化合物

相似结构搜索
InChIKey: DKYPDMHYDHHGRL-HTQZYQBOSA-N
InChI=1S/C10H8BNO8/c13-9(14)7-8(10(15)16)20-11(19-7)5-2-1-3-6(4-5)12(17)18/h1-4,7-8H,(H,13,14)(H,15,16)/t7-,8-/m1/s1
计算化学: 氢键受体数6.0氢键供体数2.0可旋转键数4.0

相似化合物

377780-80-8 1072945-06-2 871329-51-0

MSDS等安全信息

GHS符号GHS07
警示词Warning
危险描述H302-H315-H319-H335
防范说明P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
危险等级3
UN编号UN 2056 3/PG 2
危险品标志F,Xi,Xn
安全声明26-36/37-16
危险类别码11-19-36/37-40
WGK Germany3

上下游产品

L-Tartaric acid m-nitrobenzene boronic acid D-tartaric acid

合成工艺路线路线简述

📜L-酒石酸,3-硝基苯硼酸置于calcium Hydride体系中,用四氢呋喃作为反应溶剂,化学反应 1.0H,反应生成 3-硝基苯硼酸l-酒石酸酯
参考文献:使用libh 4和tarb-X对映体选择性还原芳基酮:手性路易斯酸
标题:使用libh 4和tarb-X对映体选择性还原芳基酮:手性路易斯酸
摘要:使用酒石酸衍生的硼酸酯与硼氢化锂组合使用可实现高对映选择性,从而实现芳基酮的不对称还原.手性路易斯酸tarb-X易于在1小时内制备,所得醇的对映体过量为88-99%.
DOI:10.1016/s0040-4039(02)00652-4

海关参考信息

2905122000-异丙醇
2905310000-1,2-乙二醇
2905320000-1,2-丙二醇
2905399001-1,3-丙二醇
💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
详情请参考：📖 海关编码查询和海关进出口税则

专利信息

专利号:US-9573873-B2
优先权日:2014-06-03
标题:Catalytic method for dibenzocycloheptane synthesis and allocolchicinoid synthesis
发明人：GREEN JAMES; MEHDI MARIAM; DJURDJEVIC SINISA
权利人:UNIV OF WINDSOR
摘要:In a non-limiting embodiment, there is provided a compound of formula (I), which may permit for a method or use in treating or preventing a cancer, such as pancreatic cancer or leukemia. In one embodiment, there is also provide a method of preparing a compound of formula (Ia), the method including conducting a cyclization reaction of a compound of formula (III) to obtain a compound of formula (IV), wherein conducting the cyclization reaction comprises conducting a Michael reaction in the presence of a Lewis acid.